China Cord Blood Corporation Announces Participation at the 29th Annual J.P. Morgan Healthcare Conference
HONG KONG, Dec. 8, 2010 /PRNewswire-Asia-FirstCall/ — China Cord Blood Corporation (NYSE: CO) (“CCBC” or “the Company”), the first and largest cord blood banking operator in China, today announced that the Company will participate in the 29th Annual J.P. Morgan Healthcare Conference, to be held at the Westin St. Francis Hotel in San Francisco on January 10-13, 2011.
Management attending the conference includes Ms. Tina Zheng, the Company’s Chairperson & Chief Executive Officer, and Mr. Albert Chen, the Company’s Chief Financial Officer. For further details, please contact the Company’s investor relations department, as per below, or contact your J.P. Morgan institutional sales representative.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses. Under the current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.
For more information, please contact: China Cord Blood Corporation Ms. Joeling Law Tel: (+852) 3605-8180 Email: firstname.lastname@example.org ICR, LLC In New York: Ashley M. Ammon: 1-646-277-1227 In Beijing: Wen Lei Zheng: +86-10-6583-7510
SOURCE China Cord Blood Corporation